[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $ntlas Intellia Therapeutics faces scrutiny over genome editing safety, with critics pointing to alternative therapies. Discussions also highlight the comparison between Intellia and Sarepta Therapeutics' approaches. ### About $ntlas NTLA is likely referring to Intellia Therapeutics, a genome editing company. ### Insights [#](/topic/$ntlas/insights) - $ntlas Creators hit a high of X for the day - $ntlas Creators hit an all time of X for the day - $ntlas Mentions hit a high of X for the day - $ntlas Mentions hit an all time of X for the day ### Engagements: XX [#](/topic/$ntlas/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$ntlas/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Month**: XXXXX -XX% **1-Year High**: XXXXX on 2025-05-29 **1-Year Low**: X on 2025-06-18 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$ntlas/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$ntlas/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Month**: X -XX% **1-Year High**: X on 2025-07-25 **1-Year Low**: X on 2025-05-08 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$ntlas/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$ntlas/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $ntlas in the last XX hours which is down XX% from X in the previous XX hours **Daily Average**: X **1 Month**: X -XX% **1-Year High**: X on 2025-07-25 **1-Year Low**: X on 2025-05-08 **Top assets mentioned** In the posts about $ntlas in the last XX hours [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Sarepta Therapeutics, Inc. (SRPT)](/topic/sarepta-therapeutics-inc) **Top topics mentioned** In the posts about $ntlas in the last XX hours [$alny](/topic/$alny), [genome](/topic/genome), [$srpt](/topic/$srpt), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [avg](/topic/avg), [coins real estate](/topic/coins-real-estate), [$95m](/topic/$95m), [$76356m8](/topic/$76356m8), [voodoo](/topic/voodoo), [$srpts](/topic/$srpts) ### Top Social Posts [#](/topic/$ntlas/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "@GeneInvesting @john_hersc79276 Wait once @adamfeuerstein is done with the $srpt beat he'll return to the $NTLA's genome editing is dangerous one especially if there are alternative therapies. Wait for it ;). $alny $bbio" [@RNAiAnalyst](/creator/x/RNAiAnalyst) on [X](/post/tweet/1948435492971618685) 2025-07-24 17:29:56 UTC 19.7K followers, 1203 engagements "@richtrades100 Which is still nothing compared to say $NTLA's XX% short despite Intellia's functional one-time cure nature versus $SRPT's voodoo uDystrophin" [@FidelisAurelius](/creator/x/FidelisAurelius) on [X](/post/tweet/1947672097741783071) 2025-07-22 14:56:28 UTC XXX followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Intellia Therapeutics faces scrutiny over genome editing safety, with critics pointing to alternative therapies. Discussions also highlight the comparison between Intellia and Sarepta Therapeutics' approaches.
NTLA is likely referring to Intellia Therapeutics, a genome editing company.
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-05-29
1-Year Low: X on 2025-06-18
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-07-25
1-Year Low: X on 2025-05-08
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $ntlas in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Month: X -XX%
1-Year High: X on 2025-07-25
1-Year Low: X on 2025-05-08
Top assets mentioned In the posts about $ntlas in the last XX hours
Alnylam Pharmaceuticals, Inc. (ALNY) Sarepta Therapeutics, Inc. (SRPT) Sarepta Therapeutics, Inc. (SRPT)
Top topics mentioned In the posts about $ntlas in the last XX hours
$alny, genome, $srpt, sarepta therapeutics inc, avg, coins real estate, $95m, $76356m8, voodoo, $srpts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@GeneInvesting @john_hersc79276 Wait once @adamfeuerstein is done with the $srpt beat he'll return to the $NTLA's genome editing is dangerous one especially if there are alternative therapies. Wait for it ;). $alny $bbio"
@RNAiAnalyst on X 2025-07-24 17:29:56 UTC 19.7K followers, 1203 engagements
"@richtrades100 Which is still nothing compared to say $NTLA's XX% short despite Intellia's functional one-time cure nature versus $SRPT's voodoo uDystrophin"
@FidelisAurelius on X 2025-07-22 14:56:28 UTC XXX followers, XXX engagements
/topic/$ntlas